Published on: November 28, 2019 at 10:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin; Drug: Acarbose
Sponsor: Boehringer Ingelheim
Not yet recruiting
https://ift.tt/33z1aaq
Friday, 29 November 2019
New diabetes clinical trial: Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.